Treatment with the oral antidiabetic agent troglitazone improves ß-cell responses to glucose in subjects with impaired glucose tolerance. - Cavaghan,M.; Ehrmann,D.; Byrne,M.; Polonsky,K. (J Clin Invest, 1997)